CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- 8-K Event Other events
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K/A Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- UPLOAD Other SEC-generated Letter
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- S-3 Offering Registration Statement
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes See Remarks gave up 41,633 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 177,146 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 8-K Event Delisting notice
- 8-K Event Other events
- 4 Open-market buy Director bought 10,000 shares at $0.91 ($9,095)
- 4 Open-market buy Director bought 25,000 shares at $0.91 ($22,848)
- 3 Insider Initial Statement of Ownership
Page 6 of 45 · 895 filings